Trials / Completed
CompletedNCT06762509
The Clinical Study of Botulinum Toxin Type A Injection in the Treatment of Wilson Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine · Academic / Other
- Sex
- All
- Age
- 15 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
In order to expand the treatment of Wilson disease and improve the quality of life of patients with Wilson's disease, the clinical effect of botulinum toxin type A injection on Wilson's disease was discussed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Botulinum toxin type A | Local injection of botulinum toxin type A was given at the time of enrollment |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2023-12-01
- Completion
- 2024-01-01
- First posted
- 2025-01-07
- Last updated
- 2025-01-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06762509. Inclusion in this directory is not an endorsement.